1. Home
  2. PI vs PCVX Comparison

PI vs PCVX Comparison

Compare PI & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Impinj Inc.

PI

Impinj Inc.

N/A

Current Price

$143.46

Market Cap

5.8B

Sector

Technology

ML Signal

N/A

Logo Vaxcyte Inc.

PCVX

Vaxcyte Inc.

N/A

Current Price

$55.88

Market Cap

7.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PI
PCVX
Founded
2000
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
7.0B
IPO Year
2011
2020

Fundamental Metrics

Financial Performance
Metric
PI
PCVX
Price
$143.46
$55.88
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
11
Target Price
★ $206.44
$116.40
AVG Volume (30 Days)
297.0K
★ 1.5M
Earning Date
10-28-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
★ $122,633,000.00
N/A
Revenue This Year
$10.27
N/A
Revenue Next Year
$19.25
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$87.96
$42.40
52 Week High
$215.25
$90.75

Technical Indicators

Market Signals
Indicator
PI
PCVX
Relative Strength Index (RSI) 29.87 37.04
Support Level $127.05 $53.43
Resistance Level $151.68 $62.44
Average True Range (ATR) 9.58 3.10
MACD -2.64 -0.97
Stochastic Oscillator 3.24 1.61

Price Performance

Historical Comparison
PI
PCVX

About PI Impinj Inc.

Impinj Inc operates a platform that enables wireless connectivity to everyday items by delivering each item's identity, location, and authenticity to business and consumer applications. Its platform includes endpoint integrated circuits (ICs) product, a miniature radios-on-a-chip, which attach to and identify their host items; and connectivity layer that comprises readers, gateways, and reader ICs to wirelessly identify, locate, authenticate, and engage endpoints via RAIN, as well as provide power to and communicate bidirectionally with endpoint ICs. Geographically, the company has a business presence in the Americas, Asia Pacific, Europe, Middle East and Africa, of which key revenue is derived from the operations in the Asia Pacific region.

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.

Share on Social Networks: